GT Biopharma Inc.
13F holders, Q1 2024 (March 31)1holders
$4.00avg. 13F price*
At the end of Q1 2024, 1 institutions reported holding GT Biopharma Inc. in their 13F filings. The largest holder was Retirement Group, LLC ($4).
- Company
- GT Biopharma Inc.
- CUSIP
- 36254L209
- Latest filing quarter
- Q1 2024
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 18 | $194K |
Ownership 1 holders
| Retirement Group, LLC | 0.00% | Reduce -97.7% | 1 | $4 |
"% of holder's portfolio" is GT BIOPHARMA INC's weight in each manager's 13F, not the share of GT Biopharma Inc. the manager owns.